SOUTH PLAINFIELD, N.J., Sept. 27, 2013 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that they will participate in two upcoming investor conferences.
Management will participate in a roundtable discussion at the Lazard Capital Markets' GenomeRX: Genes as......
More...







